NeuroSense Therapeutics Ltd.
NRSN
$0.83
-$0.02-2.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.21M | -3.21M | -2.35M | -2.35M | -- |
| Total Depreciation and Amortization | 4.00K | 4.00K | 4.00K | 4.00K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 894.00K | 894.00K | 153.00K | 153.00K | -- |
| Change in Net Operating Assets | 474.50K | 474.50K | 197.50K | 197.50K | -- |
| Cash from Operations | -1.84M | -1.84M | -2.00M | -2.00M | -- |
| Capital Expenditure | -1.50K | -1.50K | -2.50K | -2.50K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.00K | 4.00K | -4.00K | -4.00K | -- |
| Cash from Investing | 2.50K | 2.50K | -6.50K | -6.50K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.59M | 1.59M | 683.00K | 683.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -28.00K | -28.00K | -32.50K | -32.50K | -- |
| Cash from Financing | 1.57M | 1.57M | 650.50K | 650.50K | -- |
| Foreign Exchange rate Adjustments | 17.50K | 17.50K | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -250.00K | -250.00K | -1.36M | -1.36M | -- |